This Week’s Top Cannabis News: Stocks In Bright Green, Corporate News, And A Congressional Hearing

Jan 2020

Gynica and Lumir Lab announced they have formed a partnership focused on finding a cannabis-based treatment for endometriosis, a topic discussed in a recent Forbes article featuring Lara Parker.

 

Forbes

Read more

Early Success in Trials: Gynica Anticipates 2020 Clinical Launch

Feb 2019

Gynica’s preclinical trial of a cannabinoid-based treatment for endometriosis is already showing promising results. The study is led by Prof. Lumir Ondrej Hanus, the chemist responsible for the definition and isolation of active cannabinoid compounds in 1992.

Read more

Gynica establishing a Groundbreaking Database of Medical Cannabis Effects on Women

10 oct 2018

Gynica, Lumir Lab, and Canadian startup Strainprint have announced a partnership to develop the world’s first and largest database of the effects of cannabis on women, starting with a focus on endometriosis symptoms.

Read more